WHO grants emergency approval to AstraZeneca vaccine
UPDATED 5:45 PM PT – Monday, February 15, 2021
The World Health Organization has granted emergency approval to AstraZeneca’s coronavirus vaccine. WHO Director-General Tedros Adhanom Ghebreyesus announced on Monday the vaccine will be distributed globally through the COVAX program, aimed at stopping the pandemic.
Today @WHO gave emergency use listing to two versions of the Oxford-AstraZeneca #COVID19 vaccine, giving the green light for these vaccines to be rolled out globally through COVAX. One of the vaccines is produced by SKBio in 🇰🇷 and the other is produced by the Serum Institute 🇮🇳. https://t.co/t31bXP0aXP
— Tedros Adhanom Ghebreyesus (@DrTedros) February 15, 2021
He added the emergency approval has given the organization more reason to believe the pandemic will be brought under control worldwide. He also pointed out COVID-19 cases are falling globally.
“The number of reported cases of COVID-19 globally has now declined for the fifth consecutive week,” Ghebreyesus stated. “Last week saw the lowest number of reported weekly cases since October. So far this year, the number of weekly reported cases has fallen by almost half.”
The director general said the organization now has all the pieces in place for rapid vaccine distribution, but added they still need to ramp up production.